IP Library Granted Patent US 8,551,525
Granted Patent B2
US 8,551,525 · App. 12/977,191 · Granted Oct 8, 2013

Bone graft materials and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,525
App. No.
12/977,191
Granted
Oct 8, 2013
Kind
B2
Abstract

Compositions, materials, methods and kits for bone grafting are described. In some embodiments, a bone graft composition includes about 15% to about 20% by weight collagen, about 55% to about 70% by weight bioactive glass, and about 15% to about 30% by weight a calcium phosphate. The bioactive glass and the calcium phosphate together are about 80% to about 85% by weight of the bone graft composition. In some embodiments, a bone graft composition includes a collagen matrix and a plurality of bioactive glass particulates dispersed throughout the collagen matrix. The collagen matrix is about 20% to about 60% by weight of the bone graft composition, and the bioactive glass is about 40% to about 80% of the bone graft composition. In some embodiments, a majority of the bioactive glass particulates are about 53 μm to about 425 μm in size.

Claims (41)

1. A bone graft composition comprising: about 15% to about 20% by weight collagen; about 55% to about 70% by weight bioactive glass; and about 15% to about 30% by weight a calcium phosphate, wherein said bioactive glass and said calcium phosphate together are about 80% to about 85% by weight of said bone graft composition, and wherein at least 85% of said bioactive glass is particles within a range of 212 μm to about 425 μm.

2. The bone graft composition of claim 1 , wherein said collagen is medical grade type I collagen.

3. The bone graft composition of claim 1 , wherein said calcium phosphate comprises about 40% to about 80% tricalcium phosphate and about 20% to about 60% hydroxyapatite.

4. The bone graft composition of claim 3 , further comprising about 15% by weight medical grade type I collagen, about 55% to about 65% by weight bioactive glass, and about 20% to about 30% by weight calcium phosphate.

5. The bone graft composition of claim 4 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:55%:30%, respectively.

6. The bone graft composition of claim 4 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:60%:25%, respectively.

7. The bone graft composition of claim 4 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:65%:20%, respectively.

8. A bone graft composition, comprising: an uncompressed collagen, the collagen comprising about 15% by weight of the bone graft composition; a plurality of bioactive glass particles dispersed throughout the collagen, at least 85% of the plurality of bioactive glass particles within a range of 212 μm to about 425 μm, the plurality of bioactive glass particles comprising about 60% by weight of the bone graft composition; and a calcium phosphate dispersed throughout the collagen and the calcium phosphate material comprising about 20% to 30% by weight of the bone graft composition.

9. The bone graft composition of claim 8 , wherein the calcium phosphate is 25% to 30% by weight of the bone graft composition.

10. The bone graft composition of claim 8 , wherein the calcium phosphate is 30% by weight of the bone graft composition.

11. A bone graft composition, comprising: a collagen matrix; and a plurality of bioactive glass particulates dispersed throughout said collagen matrix, at least 85% of the plurality of bioactive glass particulates having a size within a range of 212 μm to about 425 μm; wherein said collagen matrix is about 20% to about 60% by weight of the bone graft composition and said bioactive glass is about 40% to about 80% by weight of the bone graft composition.

12. The bone graft composition of claim 11 , wherein said collagen matrix is uncompressed.

13. The bone graft composition of claim 11 , further comprising:

a calcium phosphate dispersed throughout said collagen matrix, the calcium phosphate is 25% to 30% by weight of the bone graft composition;

the plurality of bioactive glass particulates are 50% by weight of the bone graft composition.

14. The bone graft composition of claim 13 , wherein the collagen is about 20% by weight of the bone graft composition and the plurality of bioactive glass particulates is about 80% by weight of the bone graft composition.

15. The bone graft composition of claim 13 , wherein the collagen is about 40% by weight of the bone graft composition and the plurality of bioactive glass particulates is about 60% by weight of the bone graft composition.

16. The bone graft composition of claim 13 , wherein the collagen is about 60% by weight of the bone graft composition and the plurality of bioactive glass particulates is about 40% by weight of the bone graft composition.

17. The bone graft composition of claim 11 , wherein the collagen and the plurality of bioactive glass particulates collectively comprise 100% by weight of the bone graft composition.

18. A method of making a porous bone graft material of claim 1 , comprising the steps of:

a) mixing a collagen with bioactive glass particles and calcium phosphate; and

b) lyophilizing the mixture of said collagen, bioactive glass particles, and calcium phosphate to form a porous bone graft material,

wherein the lyophilized bone graft material is about 15% to about 20% by weight collagen;

about 55% to about 70% by weight bioactive glass; and about 15% to about 30% by weight a calcium phosphate,

wherein said bioactive glass and said calcium phosphate together are about 80% to about 85% by weight of said bone graft material, and

wherein at least 85% of said bioactive glass is particles within a range of 212 μm to about 425 μm.

19. The method of claim 18 , wherein said collagen is type I collagen.

20. The method of claim 18 , wherein said calcium phosphate comprises about 40% to about 80% tricalcium phosphate and about 20% to about 60% hydroxyapatite.

21. The method of claim 20 , further comprising about 15% by weight type I collagen, about 55% to about 65% by weight bioactive glass, and about 20% to about 30% by weight calcium phosphate.

22. The method of claim 21 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:55%:30%, respectively.

23. The method of claim 21 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:60%:25%, respectively.

24. The method of claim 21 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:65%:20%, respectively.

25. A method of making bone graft material of claim 1 , comprising the steps of:

mixing a collagen with calcium phosphate;

lyophilizing the mixture of collagen and calcium phosphate to form a porous bone graft material; and

disposing, after the lyophilizing, the bioactive glass onto the bone graft material wherein the bone graft material is about 15% to about 20% by weight collagen; about 55% to about 70% by weight bioactive glass; and about 15% to about 30% by weight a calcium phosphate,

wherein said bioactive glass and said calcium phosphate together are about 80% to about 85% by weight of said bone graft material, and

wherein at least 85% of said bioactive glass is particles within a range of 212 μm to about 425 μm.

26. The method of claim 25 , wherein the disposing includes wetting the bone graft material with a solution including the bioactive glass.

27. The method of claim 25 , wherein the disposing includes sprinkling the bioactive glass particles onto the bone graft material.

28. The method of claim 25 , further comprising wetting, after the lyophilizing, the porous bone graft material, wherein the disposing occurs after the wetting.

Assignments (7)
SECURITY INTEREST Recorded Aug 1, 2025
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071904/0465 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 071909/0861 →
RELEASE OF SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (040823/0983) Recorded Dec 17, 2019
From: JPMORGAN CHASE BANK, N.A,, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 051336/0511 →
SECURITY INTEREST Recorded Dec 13, 2019
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051272/0143 →
PATENT SECURITY AGREEMENT Recorded Dec 6, 2016
From: BIOVENTUS LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040823/0983 →
MERGER AND CHANGE OF NAME Recorded Nov 14, 2016
From: BIOSTRUCTURES, LLC; BIOVENTUS, LLC
To: BIOVENTUS, LLC
Reel/Frame 040311/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2011
From: COOK, RUSSELL L.; ANTONE, DURAID S.
To: BIOSTRUCTURES, LLC
Reel/Frame 026482/0048 →